COMMUNIQUÉS West-GlobeNewswire

Announcement by Heirs of Late Valerijs Maligins

28/05/2018 - 09:03

Announcement by Heirs of Late Valerijs Maligins JSC Olainfarm hereby informs that it has received the folowing announcement from heirs of Valerijs Maligins. Mutually Acceptable Agreement is Reached About Distribution of [...]

Solon Eiendom ASA : Primary insider notification

28/05/2018 - 08:31

(Oslo, Norway, May 25, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 30.000 shares in Solon Eiendom ASA at a price of NOK 28.7105. Following this [...]

Solon Eiendom ASA : Commencement of subscription period

28/05/2018 - 08:31

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

PCI Biotech: Disclosure of voting rights for Chairman of the Board

28/05/2018 - 08:31

Oslo, 28 May 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual [...]

Vistin Pharma ASA : Final result of the subsequent repair issue

28/05/2018 - 08:24

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Shire plc : Rule 2.9 Announcement

28/05/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 28 May 2018 Shire [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

28/05/2018 - 07:06

REGULATED INFORMATION GHENT, Belgium, 28 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

28/05/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 28 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Bone Therapeutics SA : Information on the total number of voting rights and shares

28/05/2018 - 07:01

Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 28 May 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions

28/05/2018 - 07:01

Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 28 mai 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]

Biocartis Group NV: Study Demonstrates Ability of Idylla(TM) EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests

28/05/2018 - 07:01

PRESS RELEASE : 28 May 2018, 07:00 CEST Study Demonstrates Ability of Idylla(TM) EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests Mechelen, Belgium, 28 May 2018 - [...]

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

28/05/2018 - 00:00

OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 27, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent [...]

Dentsply Sirona to Present at the Stifel 2018 Dental & Veterinary Conference on May 30th

27/05/2018 - 23:00

YORK, Pa., May 27, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY ), The Dental Solutions Company, today announced it will participate in the Stifel 2018 Dental & Veterinary [...]

Olainfarm will Hold First Quarter 2018 Investor Conference Webinar

27/05/2018 - 21:03

Olainfarm will Hold First Quarter 2018 Investor Conference Webinar AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on [...]

Assessment of Independence of Candidates for Membership in Supervisory Council of JSC Olainfarm

27/05/2018 - 20:56

Assessment of Independence of Candidates for Membership in Supervisory Council of JSC Olainfarm Assessment of independence of Candidates for Membership in Supervisory Council of JSC Olainfarm according to Annex III “ [...]

Allergy experts: "Clinical effect of ALK’s tree SLIT-tablet among the most significant ever seen in allergy immunotherapy trials"

27/05/2018 - 12:15

Leading allergy researchers present Phase III data on tree SLIT-tablet at EAACI Annual Congress in Munich Birch pollen-based product shown to be effective against multiple tree allergies Effect shown to be comparable [...]

Genmab Announces that Janssen Will Stop Studies of Daratumumab in Combination with Anti-PD-(L)1

26/05/2018 - 09:55

Company Announcement Based on a recent planned review, the Data Monitoring Committee (DMC) recommends Phase Ib/II study of daratumumab plus atezolizumab (anti PD-L1 antibody) in patients with previously treated non- [...]

BODY GLOBE BODY ARMOR® RECEIVES NOTICE OF ALLOWANCE (NOA) NOTICE FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HOVERINK BIOTECHNOLOGIES ANNOUNCES.

26/05/2018 - 03:01

LOS ANGELES, CA, May 25, 2018 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it has received its NOTICE OF ALLOWANCE (NOA) from the UNITED STATES PATENT AND TRADEMARK OFFICE for its BODY GLOBE BODY [...]

Latvijas Juras medicinas centrs JSC: interim report for the 3 months of 2018.

25/05/2018 - 22:49

Latvia, 2018-05-25 22:49 CEST (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: interim report for the 3 months of 2018, approved by the Board at 25.05.2018. Member of the Board: Juris Imaks, phone: 29512492